2023年7月3日～2023年7月9日の間に収集した論文情報を追加しました。(1/3)
①Disproportionality Analysis of Abemaciclib in the FDA Adverse Event Reporting System: A Real-World Post-Marketing Pharmacovigilance Assessment.
アベマシクリブの有害事象評価研究
対象DB：FAERS
②Seizures associated with antibiotics: A real-world disproportionality analysis of FAERS database.
抗生物質と発作の関連性評価研究
対象DB：FAERS
③Adverse events related to darolutamide treatment: analysis of "real life" data from EudraVigilance and the Food and Drug Administration database entries.
ダロルタミドに関連する有害事象評価研究
対象DB：FAERS、EudraVigilance
④Atypical femur fracture associated with common anti-osteoporosis drugs in FDA adverse event reporting system.
抗骨粗鬆症薬による非定型大腿骨骨折のリスク調査研究
対象DB：FAERS
⑤Neuropsychiatric adverse reactions in patients treated with denosumab: two case reports and a review of data from the FDA Adverse Event Reporting System (FAERS).
デノスマブ投与患者における精神、神経系の有害事象評価研究
対象DB：FAERS
⑥Urological complications after COVID 19 vaccine according to age, sex and manufacturer.
COVID-19ワクチン接種後における泌尿器系有害事象のリスク調査研究
対象DB：VAERS
⑦Disproportionality analysis on hypothyroidism with roxadustat using the japanese adverse drug event database.
HIF-PHIの甲状腺機能への影響調査研究
対象DB：JADER